Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours

European Journal of Cancer

Volumn 36, Issue 18, 2000, Pages 2420-2429

  Van Moorsel, C J A ^a   Pinedo, H M ^a   Smid, K ^a   Comijn, E M ^a   Voorn, D A ^a   Veerman, G ^a   Lakerveld, B ^a   Van der Vijgh, W J F ^a   Giaccone, G ^a   Postmus, P E ^b   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cisplatin; Gemcitabine; Murine; Non small cell lung cancer; Pharmacodynamics; Pharmacokinetics; Schedule

Indexed keywords

CISPLATIN; GEMCITABINE; PHOSPHORUS 32; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DNA BINDING; DRUG POTENTIATION; DRUG RETENTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LUNG NON SMALL CELL CANCER; MOUSE; NEPHROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; KIDNEY; MICE; MICE, INBRED C57BL;

EID: 0033694990     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00345-2     Document Type: Article

References (45)

1. Synthesis of 2'-deoxy-2',2'-difluoro-d-ribose and 2'-deoxy-2',2'-difluoro-d-ribofuranosyl nucleosides
2. Gemcitabine: Future prospects of single-agents and combination studies
3. Action of 2',2'-difluorodeoxycytidine on DNA synthesis
4. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-β-d-arabinofuranosylcytosine
5. 2',2'-Difluoro-deoxycytidine (Gemcitabine) incorporation into RNA and DNA of tumour cell lines
6. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small cell lung cancer cell lines
7. The coordination chemistry of platinum anticancer drugs and related compounds with DNA
8. Correlation between cell killing by cisdiamminedichloroplatinum(II) in six mammalian cell lines and binding of a cisdiamminedichloroplatinum(II)-DNA antiserum
9. Platinum DNA-damage in leucocyte DNA of patients receiving cisplatin and carboplatin chemotherapy, measured by atomic absorption spectrometry
10. Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
11. Synergistic interaction between cisplatin and gemcitabine in vitro
12. Scheduling of gemcitabine and cisplatin in Lewis Lung tumor bearing mice
13. Biologic characterization of the subcutaneously implanted Lewis Lung tumor
14. UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia. 2nd edn
15. Tissue homogenization using a microdismembrator for the measurement of enzyme activities
16. Schedule-dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumor cell lines and solid tumors
17. Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients
18. 322P-postlabelling
19. 32P-postlabelling assay for the quantification of the major platinum-DNA adducts
20. Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
21. Adducts of the antitumor drug cis-diammine-dichloroplatinum(II) with DNA: Formation, identification and quantitation
22. Regulation of deoxycytidine kinase from solid tumor cell lines by CTP and UTP
23. 2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation
24. A topographic study on the distribution of cisplatin in xenografted tumors on nude mice
25. Pharmacodynamics of cisplatin in human head and neck cancer: Correlation between platinum content, DNA-adduct levels and drug sensitivity in vitro and in vivo
26. Comparative activity and distribution of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts
27. Modulation of cis-diamminedichloroplatinum(II) resistance: A review
28. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines
29. Effects of gemcitabine (dFdC) on formation and repair of platinum(Pt)-DNA adducts in ovarian cancer cell lines
30. Preclinical characteristics of gemcitabine
31. Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA
32. DNA lesion-recognizing proteins and the p53 connection
33. Correlation between cell killing by cisdiamminedichloroplatinum(II) in six mammalian cell lines and binding of a cisdiamminedichloroplatinum(II)-DNA antiserum
34. Platinum DNA-damage in leukocyte DNA of patients receiving cisplatin and carboplatin chemotherapy, measured by atomic absorpotion spectrometry
35. Quantification of cis-diammine-dichloroplatinum II (cisplatin)-DNA intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy
36. The measurements of cisDDP-DNA adduct levels in testicular cancer patients
37. Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients
38. Cisplatin- and carboplatin-DNA adducts: Is Pt-AG the cytotoxic lesion?
39. Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: A phase II study
40. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
41. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small cell lung cancer
42. Phase I/II study of gemcitabine and cisplatin in non-small cell lung cancer: Preliminary results
43. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
44. Weekly gemcitabine and cisplatin in advanced non-small cell lung cancer: A phase II study
45. Combined cisplatin and gemcitabine for non-small cell lung cancer: Influence of scheduling of toxicity and drug delivery